HRTX Wutah pendapatan triwulanan Heron Therapeutics, Inc.

Simbol lan logo merek herontx.com (HRTX)

Risks stemming from dependence on Asian raw materials and logistical disruptions are impacting the stability of Heron Therapeutics (HRTX). Quarterly revenue dynamics clearly demonstrate these fluctuations, and the metric currently stands at -7.90. Meanwhile, the company is successfully implementing non-opioid analgesics to replace opioids, while the automation of shipments via third-party contractors completely eliminates supply chain downtime.

herontx.com (HRTX) - Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 21.11.2026

Heron Therapeutics Inc (HRTX) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:herontx.com (HRTX)
Barang unggulan Heron

Heron Therapeutics (HRTX) is automating drug packaging and digitizing hospital accounting to minimize manual labor. The quarterly revenue growth rate measures the pace of sales changes, allowing for an assessment of the business's scaling speed. This chart reflects cash flow sensitivity to market shocks by comparing current and previous periods. A stable trend confirms the issuer's capital resilience and solvency.

Pesaing utama

INCY - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur HUTCHMED (HCM)|NUVB: Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Day One Bio DAWN|Wutah dodolan triwulanan MNPR|Tingkat wutah pendapatan sajrone kuartal Inhibrx Biosciences INBX|Wutah dodolan triwulanan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Tambahing pendapatan triwulanan|Nuvectis Pharma, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal CHRS (Coherus BioSciences)|Corbus Pharma - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan CRDF (cardiffoncology.com)|BYSI: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal BioAtla Corp (BCAB)|Wutah pendapatan kuartal marang kuartal Lixte Biotechnology Holdings, Inc.|CTXR: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan CLRB|Wutah pendapatan triwulanan BioLineRx Corporation (BLRX)|Wutah pendapatan kuartal marang kuartal Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Dinamika pendapatan kuartal marang kuartal|KZIA: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Silexion Therapeutics|NuCana plc (NCNA) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Chimerix, Inc|Wutah dodolan triwulanan CYCC|Wutah dodolan triwulanan G1 Therapeutics (GTHX)|Wutah pendapatan kuartal marang kuartal Kronos Bio Corporation (KRON)|Kintara - Wutah dodolan kuartal marang kuartal|Oncternal Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal PRTG (Portage)